≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Chromosomal abnormalities, not elsewhere classified

DOID EFO Endpoint Browser PheWeb

Q17_CHROMOSOMAL_ABNORMALITI_NOT_ELSEW_CLASSIFIED

Klinefelter's syndrome: A sex chromosome disorder caused by the presence of an extra X chromosome in the male karyotype. Affected individuals are infertile and have a small penis and testes. They tend to have tall stature and long legs and may have difficulties with speech and language development. Gynecomastia may be present.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — Q90-Q99
  • Cause of death: ICD-10 — Q90-Q99

2 out of 7 registries used, show all original rules.

793

4. Check minimum number of events

None

793

5. Include endpoints

793

6. Filter based on genotype QC (FinnGen only)

793

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Q
Name in latin
Abnormitates chromosomales non alibi classificatae

Similar endpoints

↥

List of similar endpoints to Chromosomal abnormalities, not elsewhere classified based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 793 459 334
Unadjusted period prevalence (%) 0.15 0.16 0.15
Median age at first event (years) 26.60 29.97 21.97

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
673
Matched controls
6711
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z31.5
ICD-10 Finland
Genetic counselling
19.3
176.4
291
255
Q99.8
ICD-10 Finland
Other specified chromosome abnormalities
+∞
108.2
101
*
Q90.9
ICD-10 Finland
Down syndrome, unspecified
+∞
93.9
88
*
Q95.0
ICD-10 Finland
Balanced translocation and insertion in normal individual
+∞
90.6
85
*
Q90.0
ICD-10 Finland
Trisomy 21, meiotic nondisjunction
+∞
75.4
71
*
Q98.0
ICD-10 Finland
Klinefelter syndrome karyotype 47,XXY
+∞
72.1
68
*
Q98.4
ICD-10 Finland
Klinefelter syndrome, unspecified
+∞
43.2
41
*
Q93.8
ICD-10 Finland
Other deletions from the autosomes
+∞
42.1
40
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
19.4
38.6
59
33
O35.1
ICD-10 Finland
Maternal care for (suspected) chromosomal abnormality in fetus
13.8
36.0
63
50
F83
ICD-10 Finland
Mixed specific developmental disorders
8.0
31.1
73
101
Q93.5
ICD-10 Finland
Other deletions of part of a chromosome
+∞
30.4
29
*
Q90
ICD-10 Finland
Down syndrome
+∞
29.4
28
*
Q99.2
ICD-10 Finland
Fragile X chromosome
+∞
28.3
27
*
P85
ICPC
Mental retardation
18.0
28.3
44
26
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
13.6
26.5
46
36
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
6.9
25.7
66
104
7580A
ICD-9 Finland
Chromosomal anomalies, Down's syndrome
+∞
25.1
24
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.6
22.6
112
355
Q98.5
ICD-10 Finland
Karyotype 47,XYY
+∞
20.9
20
*
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
17.6
20.6
32
19
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.6
20.3
100
314
MAA10
NOMESCO Finland
Biopsy of chorionic villus
49.5
20.3
24
5
R62.0
ICD-10 Finland
Delayed milestone
5.1
19.9
65
139
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.8
19.8
143
587
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.8
19.0
86
252
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
18.2
237
1321
MAA00
NOMESCO Finland
Amniocentesis
7.1
17.5
43
64
N46
ICD-10 Finland
Male infertility
8.8
17.4
37
44
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
3.3
17.1
91
303
N96
ICD-10 Finland
Habitual aborter
16.1
15.8
25
16
Z82.7
ICD-10 Finland
Family history of congenital malformations, deformations and chromosomal abnormalities
19.7
15.6
23
12
Z36.0
ICD-10 Finland
Antenatal screening for chromosomal anomalies
3.7
15.3
69
201
XF400
NOMESCO Finland
ECG with 12 standard connections
2.5
15.1
135
618
SPAT1229
SPAT
Assessment of need for aid
5.2
14.7
46
94
75930
ICD-8 Finland
Congenital syndromes affecting multiple systems, Down's disease
+∞
14.6
14
*
Q95.1
ICD-10 Finland
Chromosome inversion in normal individual
+∞
14.6
14
*
Q96.3
ICD-10 Finland
Mosaicism, 45,X/46,XX or XY
+∞
14.6
14
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
14.1
208
1198
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
13.9
232
1399
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.4
13.8
69
219
H65.3
ICD-10 Finland
Chronic mucoid otitis media
3.3
13.7
71
231
Q98.8
ICD-10 Finland
Other specified sex chromosome abnormalities, male phenotype
+∞
13.6
13
*
MA4AT
NOMESCO Finland
Chorion biopsy with ultrasound guidance
16.6
13.5
21
13
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
13.2
126
593
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.8
13.1
88
342
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.2
12.9
69
231
E29.1
ICD-10 Finland
Testicular hypofunction
10.3
12.5
24
24
Q97.0
ICD-10 Finland
Karyotype 47,XXX
+∞
12.5
12
*
Q99.9
ICD-10 Finland
Chromosomal abnormality, unspecified
+∞
12.5
12
*
Q90.1
ICD-10 Finland
Trisomy 21, mosaicism (mitotic nondisjunction)
+∞
12.5
12
*
F79.9
ICD-10 Finland
Unspecified mental retardation, without mention of impairment of behaviour
20.5
12.5
18
9
L28
ICPC
Limited function/disability (L)
3.0
12.2
71
252
N05AX08
ATC
risperidone; systemic
3.1
11.8
66
225
XA800
NOMESCO Finland
Neuropsychological investigation
3.0
11.6
67
236
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.2
11.5
131
669
H01AC01
ATC
somatropin; parenteral
4.6
11.5
39
88
Q96.0
ICD-10 Finland
Karyotype 45,X
+∞
11.5
11
*
Q96.8
ICD-10 Finland
Other variants of Turner syndrome
+∞
11.5
11
*
201
Kela drug reimbursment
Chronic cardiac insufficiency
5.8
11.3
31
55
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
11.2
170
980
F71.0
ICD-10 Finland
Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour
20.4
11.2
16
8
Q21.21
ICD-10 Finland
Atrioventricular duct
44.0
10.9
13
*
F82
ICD-10 Finland
Specific developmental disorder of motor function
4.8
10.7
35
76
Z3226
NOMESCO Finland
Physiotherapist
2.0
10.7
156
880
H50.30
ICD-10 Finland
Intermittent esotropy
6.5
10.7
27
43
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.1
10.7
41
105
UDC00
NOMESCO Finland
Ear microscopy
2.9
10.6
65
237
N97.8
ICD-10 Finland
Female infertility of other origin
6.0
10.5
28
48
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.1
10.5
40
102
Q98.6
ICD-10 Finland
Male with structurally abnormal sex chromosome
+∞
10.4
10
*
Q95.8
ICD-10 Finland
Other balanced rearrangements and structural markers
+∞
10.4
10
*
Q91.0
ICD-10 Finland
Trisomy 18, meiotic nondisjunction
+∞
10.4
10
*
ZXE00
NOMESCO Finland
One hour or less
1.7
10.3
276
1915
Q21.10
ICD-10 Finland
Persistent ostium secundum
5.4
10.1
29
55
DFF20
NOMESCO Finland
Audiometry for children
4.6
10.1
34
77
Z3229
NOMESCO Finland
Other healthcare associate professional
2.5
10.1
79
335
H52.2
ICD-10 Finland
Astigmatism
4.0
9.9
39
102
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.1
9.9
53
178
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
9.9
121
633
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
3.0
9.8
57
202
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
20.3
9.8
14
7
Z2221
NOMESCO Finland
Medical doctor
1.8
9.6
196
1246
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
9.5
241
1635
Q21.11
ICD-10 Finland
Paten or persistent foramen ovale
7.7
9.5
21
28
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.3
9.4
88
408
Q97.2
ICD-10 Finland
Mosaicism, lines with various numbers of X chromosomes
+∞
9.4
9
*
Q92.3
ICD-10 Finland
Minor partial trisomy
+∞
9.4
9
*
Q90.2
ICD-10 Finland
Trisomy 21, translocation
+∞
9.4
9
*
J01DB01
ATC
cefalexin; oral
1.7
9.4
501
4198
G91.0
ICD-10 Finland
Communicating hydrocephalus
22.0
9.4
13
6
H03AA01
ATC
levothyroxine sodium; systemic
2.0
9.3
121
649
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.1
9.3
119
634
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
9.3
55
198
WX400
NOMESCO Finland
Inhalation anesthesy
2.7
9.2
63
248
Q25.0
ICD-10 Finland
Patent ductus arteriosus
6.0
9.1
24
41
ZXA10
NOMESCO Finland
Bilateral
2.1
9.0
115
613
101
Kela drug reimbursment
Anterior pituitary hypofunction
5.0
8.6
26
53
R1250
NOMESCO Finland
Evaluation of functional capability
5.5
8.5
24
45
Z2446
NOMESCO Finland
Social worker
2.1
8.4
99
508
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
6.8
8.4
20
30
O02.1
ICD-10 Finland
Missed abortion
2.9
8.4
52
191
N03AG01
ATC
valproic acid; systemic, rectal
2.6
8.4
60
242
Z2445
NOMESCO Finland
Psychologist
2.3
8.4
77
355
KFB01
NOMESCO Finland
Microscope-assisted testicular biopsy for assisted reproduction treatments
+∞
8.3
8
*
Q95.2
ICD-10 Finland
Balanced autosomal rearrangement in abnormal individual
+∞
8.3
8
*
Q92.8
ICD-10 Finland
Other specified trisomies and partial trisomies of autosomes
+∞
8.3
8
*
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
9.6
8.3
16
17
Q21.08
ICD-10 Finland
Other specifed ventricular septal defect
5.0
8.3
25
51
ZXD05
NOMESCO Finland
Urgent procedure
1.7
8.2
200
1329
Z3231
NOMESCO Finland
Registered nurse
1.7
8.2
209
1410
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
4.3
8.2
29
70
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
8.0
364
2855
R4110
NOMESCO Finland
Physiotherapy
1.8
8.0
165
1043
C03CA01
ATC
furosemide; systemic
2.4
7.9
66
288
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.5
7.9
36
108
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.7
7.9
212
1447
ZXE20
NOMESCO Finland
More than three and less than five hours
2.1
7.8
85
423
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
3.6
7.7
33
95
Z36.2
ICD-10 Finland
Other antenatal screening based on amniocentesis
25.3
7.6
10
*
F79
ICD-10 Finland
Unspecified mental retardation
25.3
7.6
10
*
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
2.3
7.5
71
330
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
7.4
88
452
F71
ICD-10 Finland
Moderate mental retardation
80.8
7.4
8
*
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
13.5
7.4
12
9
Z50.5
ICD-10 Finland
Speech therapy
2.9
7.4
43
154
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
7.3
130
778
Q93.0
ICD-10 Finland
Whole chromosome monosomy, meiotic nondisjunction
+∞
7.3
7
*
Q91.2
ICD-10 Finland
Trisomy 18, translocation
+∞
7.3
7
*
Q92.6
ICD-10 Finland
Extra marker chromosomes
+∞
7.3
7
*
Y28
ICPC
Limited function/disability (Y)
15.9
7.2
11
7
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
6.1
7.1
18
30
F79.1
ICD-10 Finland
Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment
12.2
7.1
12
10
WX610
NOMESCO Finland
Patient controlled analgesia
8.9
7.1
14
16
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
7.1
7.0
16
23
N06DA02
ATC
donepezil; oral
7.6
6.9
15
20
RS222
NOMESCO Finland
NA
4.9
6.9
21
44
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
6.8
99
554
R2110
NOMESCO Finland
Giving the first information
2.5
6.8
51
213
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
2.6
6.8
47
187
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
6.7
214
1516
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.2
6.7
66
313
SPAT1216
SPAT
Assessment of functional ability
2.3
6.7
61
282
R1260
NOMESCO Finland
Evaluation of communicative skills
5.2
6.7
19
37
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
4.3
6.7
23
55
A28
ICPC
Limited function/disability NOS
2.4
6.6
55
242
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
2.1
6.6
72
361
G02CB01
ATC
bromocriptine; systemic
4.9
6.6
20
42
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
6.6
130
806
P05.1
ICD-10 Finland
Small for gestational age
6.9
6.5
15
22
DFF00
NOMESCO Finland
Pure tone audiometry
2.4
6.5
52
226
G30.0
ICD-10 Finland
Alzheimer disease with early onset
70.3
6.4
7
*
N06DX01
ATC
memantine; oral
7.5
6.4
14
19
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
6.4
64
307
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
6.3
300
2328
FM2CE
NOMESCO Finland
NA
2.6
6.3
44
175
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.2
6.3
64
311
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.6
6.3
42
165
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
4.6
6.3
20
44
SPAT1231
SPAT
Assessment of adjustments needed in living environment
9.4
6.3
12
13
G91.1
ICD-10 Finland
Obstructive hydrocephalus
9.4
6.3
12
13
K03.66
ICD-10 Finland
Tooth plaque
2.0
6.3
76
396
XF600
NOMESCO Finland
Bloodpressure measurement
2.2
6.3
65
316
N05CD08
ATC
midazolam; nasal, systemic
3.5
6.3
27
79
Q92.5
ICD-10 Finland
Duplications with other complex rearrangements
+∞
6.3
6
*
Q97.8
ICD-10 Finland
Other specified sex chromosome abnormalities, female phenotype
+∞
6.3
6
*
Q96.9
ICD-10 Finland
Turner syndrome, unspecified
+∞
6.3
6
*
7456C
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Endocardial cushion defects[ASD CANALIS ATRIOVENTRICULARIS COMMUNIS]
+∞
6.3
6
*
Q91.1
ICD-10 Finland
Trisomy 18, mosaicism (mitotic nondisjunction)
+∞
6.3
6
*
Q98.1
ICD-10 Finland
Klinefelter syndrome, male with more than two X chromosomes
+∞
6.3
6
*
R4120
NOMESCO Finland
Occupational therapy
2.3
6.2
53
236
F71.1
ICD-10 Finland
Moderate mental retardation, significant impairment of behaviour requiring attention or treatment
26.9
6.2
8
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.3
6.2
55
249
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
2.7
6.2
38
143
H52.0
ICD-10 Finland
Hypermetropia
3.3
6.2
29
91
R50.9
ICD-10 Finland
Fever, unspecified
1.8
6.2
119
733
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.7
6.2
128
804
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
7.8
6.1
13
17
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
4.1
6.1
22
55
N05BA09
ATC
clobazam; oral
4.7
6.1
19
41
M41.4
ICD-10 Finland
Neuromuscular scoliosis
12.6
6.1
10
8
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
6.1
115
703
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.1
6.1
66
329
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
8.7
6.1
12
14
A41.9
ICD-10 Finland
Sepsis, unspecified
3.5
6.1
26
76
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
3.6
6.0
25
71
O35.9
ICD-10 Finland
Maternal care for (suspected) fetal abnormality and damage, unspecified
6.1
6.0
15
25

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40765089) Chromosome analysis panel - Blood by G-banded
69
71
10.52
60.45
1.0
1.0
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
109
407
2.94
21.50
2.8
1.8
u/l
9.2
7.5
0.79
83
293
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
61
192
3.35
15.98
1.5
1.4
ug/l
4.9
3.6
0.24
51
175
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
74
277
2.84
14.41
3.1
4.9
ng/l
116.6
179.2
0.99
68
245
(3017446) Testosterone [Moles/volume] in Serum or Plasma
114
530
2.34
14.20
5.0
2.2
nmol/l
11.8
12.6
0.52
103
459
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
155
825
2.09
13.80
4.3
4.4
ng/l
755.9
756.1
0.00
133
673
(3023323) Follitropin [Units/volume] in Serum or Plasma
112
531
2.29
13.30
2.4
1.7
iu/l
17.5
18.4
0.14
91
409
(3032080) INR in Blood by Coagulation assay
246
1605
1.77
11.57
7.8
5.7
inr
1.1
1.1
0.01
65
513
(3003458) Phosphate [Moles/volume] in Serum or Plasma
166
962
1.91
11.45
6.8
10.1
mmol/l
1.2
1.2
0.81
159
920
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
347
2500
1.68
11.32
11.6
10.6
mmol/l
1.2
1.2
1.09
325
2349
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
17
26
6.64
10.63
1.0
1.0
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
40
127
3.25
10.36
4.3
5.7
umol/l
423.0
396.4
0.50
35
116
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
333
2420
1.64
10.20
3.1
2.9
nmol/l
72.0
71.6
0.08
318
2290
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
583
4883
1.72
10.12
4.9
3.8
pmol/l
14.6
14.4
1.04
553
4575
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
145
840
1.88
9.91
3.5
3.3
ng/l
470.5
846.0
0.90
96
509
(3018418) pH of Serum or Plasma
209
1352
1.74
9.90
4.5
3.9
ph
7.4
7.4
0.45
41
233
(3023368) Bacteria identified in Blood by Culture
186
1178
1.75
9.44
4.8
4.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
362
2725
1.60
9.37
10.8
10.1
mmol/l
1.2
1.2
0.52
313
2426
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
12
5
24.25
8.91
1.2
1.0
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
287
2065
1.61
8.84
4.9
6.8
g/l
36.3
37.2
2.34
272
1951
(42870588) Differential panel, method unspecified - Blood
329
2451
1.58
8.71
6.4
8.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
107
584
1.96
8.69
1.2
1.3
iu/ml
139.9
151.1
0.09
39
229
(3013826) Glucose [Moles/volume] in Serum or Plasma
415
3301
1.53
7.95
7.8
6.6
mmol/l
6.3
6.3
0.10
389
3046
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
642
5661
1.69
7.67
5.6
4.3
mu/l
2.0
2.0
0.01
613
5356
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
341
2631
1.51
7.35
6.3
7.1
umol/l
16.3
16.0
0.06
321
2474
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
493
4107
1.52
7.35
7.1
6.7
u/l
95.8
92.8
0.44
475
3887
(43055514) Macroprolactin [Presence] in Serum or Plasma
13
24
5.48
6.76
1.2
1.5
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
40
162
2.54
6.74
2.8
1.8
pmol/l
186.2
215.5
0.79
40
153
(3007853) Bacteria identified in Skin by Aerobe culture
124
770
1.72
6.60
2.6
1.7
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
42
177
2.44
6.52
2.1
1.4
nmol/l
0.3
0.4
0.59
37
143
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
51
237
2.22
6.35
2.4
1.8
nmol/l
34.5
36.6
0.34
51
231
(3012095) Magnesium [Moles/volume] in Serum or Plasma
137
888
1.65
6.19
4.6
8.5
mmol/l
0.8
0.8
0.13
128
844
(3002179) Metamyelocytes/100 leukocytes in Blood
74
406
1.90
5.92
3.4
5.2
%
1.0
0.5
0.60
14
97
(3021440) Promyelocytes/100 leukocytes in Blood
75
414
1.89
5.89
3.8
5.5
%
0.2
0.1
0.24
19
123
(3017181) Myelocytes/100 leukocytes in Blood
78
441
1.85
5.69
3.7
5.4
%
1.2
0.9
0.37
21
136
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
111
696
1.69
5.68
3.0
2.9
%
22.3
23.8
0.71
96
625
(3000494) Fungus identified in Specimen by Culture
103
642
1.69
5.39
1.4
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
78
454
1.79
5.19
15.2
11.6
mmol/l
0.6
0.7
0.08
59
354
(3027801) Oxygen [Partial pressure] in Arterial blood
77
453
1.77
4.95
15.3
11.6
kpa
13.0
13.9
0.66
72
434
(3026008) Bacteria identified in Urine by Culture
189
1382
1.48
4.94
2.8
2.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
125
836
1.58
4.94
3.0
2.7
umol/l
13.9
14.6
0.48
115
785
(3006315) Basophils [#/volume] in Blood
416
3501
1.39
4.93
6.9
8.1
e9/l
0.0
0.0
0.89
364
2962
(40761511) CBC panel - Blood by Automated count
724
6770
1.77
4.93
13.3
9.3
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
77
454
1.77
4.91
15.3
11.6
kpa
5.2
5.2
0.04
72
434
(3001604) Monocytes [#/volume] in Blood
415
3499
1.38
4.82
6.9
8.0
e9/l
0.6
0.6
0.70
362
2960
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
179
1301
1.48
4.82
2.3
2.2
u/l
259.9
289.8
0.13
172
1250
(3023103) Potassium [Moles/volume] in Serum or Plasma
666
6111
1.55
4.78
16.4
12.2
mmol/l
4.0
3.9
2.10
645
5933
(36660697) Celiac disease serology panel - Serum
126
851
1.57
4.77
1.3
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
47
238
2.03
4.76
17.4
16.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
383
3196
1.38
4.70
9.2
10.3
e9/l
0.0
0.0
0.51
313
2502
(3019550) Sodium [Moles/volume] in Serum or Plasma
664
6095
1.53
4.69
16.6
12.2
mmol/l
139.4
139.5
0.69
645
5938
(3025159) Blasts/100 leukocytes in Blood
69
400
1.79
4.67
3.8
5.6
%
0.2
0.1
0.24
17
104
(3002173) Hemoglobin [Mass/volume] in Arterial blood
63
356
1.83
4.63
13.0
11.5
g/l
128.7
123.9
1.00
58
346
(3019309) Folate [Moles/volume] in Red Blood Cells
90
565
1.66
4.59
1.5
1.6
nmol/l
1199.8
1150.3
0.13
73
453
(3026782) Osmolality of Urine
162
1167
1.48
4.54
2.8
2.9
mosm/kgh2o
547.4
580.2
0.95
150
1002
(3030467) Casts [#/volume] in Urine by Automated count
217
1655
1.42
4.50
3.4
3.5
e6/l
0.3
0.3
0.55
173
1223
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
39
745
0.50
4.49
1.6
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
257
2020
1.40
4.48
3.9
3.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
90
571
1.65
4.41
2.0
1.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
232
1799
1.40
4.36
3.5
3.6
e6/l
48.0
77.2
0.30
186
1350
(3038071) Oxygen [Partial pressure] in Mixed venous blood
11
26
4.26
4.35
3.5
8.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
423
3614
1.36
4.34
7.3
8.8
e9/l
0.2
0.2
1.15
374
3116
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
267
2122
1.38
4.33
1.7
1.5
u/ml
3.9
2.7
0.31
66
468
(3007164) IgA [Mass/volume] in Serum or Plasma
248
1947
1.39
4.33
1.9
1.6
g/l
1.9
1.9
0.05
133
1102
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
90
577
1.63
4.23
2.1
2.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
15
46
3.30
4.18
1.7
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
98
644
1.59
4.17
4.9
6.0
%
1.6
1.5
0.25
88
599
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
11
27
4.11
4.15
3.5
8.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
447
3870
1.35
4.12
8.8
10.8
e9/l
3.8
3.8
0.02
389
3290
(3019198) Lymphocytes [#/volume] in Blood
422
3623
1.35
4.10
6.9
8.0
e9/l
2.1
2.2
1.06
380
3132
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
179
1339
1.43
4.09
1.8
1.8
mmol/l
1.5
1.4
0.40
151
1195
(3019060) Gas panel - Arterial blood
41
211
1.99
4.01
6.8
6.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
111
760
1.53
3.95
3.0
2.7
g/l
2.5
2.5
0.08
105
712
(3000991) Gas panel - Venous blood
117
812
1.51
3.91
12.4
11.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
175
1315
1.42
3.89
1.9
3.0
mg/l
1.0
1.3
0.49
137
974
(3002032) Base excess in Venous blood by calculation
125
881
1.49
3.88
5.9
10.0
mmol/l
1.3
1.2
0.18
100
691
(3022096) Basophils/100 leukocytes in Blood
382
3249
1.33
3.88
7.3
8.3
%
0.7
0.7
0.09
365
3099
(3006504) Eosinophils/100 leukocytes in Blood
392
3348
1.33
3.86
7.2
8.2
%
2.8
3.0
0.62
377
3189
(3000850) Epithelial cells [#/volume] in Urine
161
1194
1.43
3.84
2.7
2.9
e6/l
6.4
7.0
0.16
151
1049
(40767503) Oxygen content in Capillary blood by calculation
23
95
2.46
3.81
2.3
3.1
%
18.9
17.2
1.18
13
51
(3012516) Albumin [Mass/volume] in Urine
135
970
1.47
3.81
3.9
3.4
mg/l
96.3
359.9
1.29
105
682
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
697
6532
1.53
3.76
10.3
9.0
u/l
29.7
27.6
1.13
683
6354
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
26
536
0.47
3.75
1.4
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
117
821
1.49
3.71
3.2
3.5
ug/l
1.1
1.9
1.51
103
749
(3019069) Monocytes/100 leukocytes in Blood
393
3372
1.32
3.69
7.4
8.4
%
8.4
8.2
0.88
379
3227
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
110
766
1.50
3.62
2.1
2.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
104
716
1.52
3.61
2.6
2.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
36
184
2.00
3.61
1.5
1.3
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
24
104
2.34
3.60
1.4
1.3
g/l
0.5
0.3
0.87
19
80
(4062490)
24
104
2.34
3.60
1.4
1.3
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
24
104
2.34
3.60
1.4
1.3
g/l
7.0
6.0
0.95
18
82
(3028192) IgG subclass 2 [Mass/volume] in Serum
24
104
2.34
3.60
1.4
1.3
g/l
2.2
2.4
0.17
19
81
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
562
5088
1.35
3.56
3.6
3.2
mmol/l
5.8
5.6
1.16
519
4751
(3052851) Hemolysis interference index of Serum or Plasma
36
185
1.99
3.56
2.8
3.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
137
1003
1.44
3.50
4.8
4.1
mg/mmol
14.1
27.2
0.37
104
694
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
76
493
1.59
3.43
1.1
1.1
—
2.8
—
0
5
(3008152) Bicarbonate [Moles/volume] in Arterial blood
39
209
1.91
3.43
9.0
9.5
mmol/l
24.3
24.4
0.07
34
196
(3014111) Lactate [Moles/volume] in Serum or Plasma
78
510
1.58
3.41
15.0
13.7
mmol/l
1.3
1.3
0.13
73
476
(3044640) Blood type and Crossmatch panel - Blood
225
1797
1.35
3.41
2.6
2.8
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
34
174
1.99
3.41
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
34
174
1.99
3.41
1.4
1.4
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
28
133
2.14
3.41
2.7
3.9
%
13.1
9.4
0.46
21
114
(36304419) Bacteria [Presence] in Urine
212
1679
1.35
3.39
3.3
3.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
692
6503
1.48
3.38
15.3
11.3
mg/l
23.0
21.0
0.83
538
4828
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
27
127
2.16
3.37
2.7
4.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
9
18
5.03
3.37
2.0
2.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
120
1614
0.70
3.33
2.2
2.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
95
653
1.51
3.33
1.6
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
204
1611
1.35
3.32
3.0
3.0
mmol/l
2.4
2.4
0.97
188
1472
(40768443) Skin Pathology biopsy report
34
176
1.97
3.31
1.1
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
519
4668
1.32
3.30
5.0
4.1
mmol/mol
37.8
37.8
0.03
486
4448
(3051611) Lipemic interference index of Serum or Plasma
19
77
2.50
3.29
2.7
3.8
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
403
3505
1.30
3.29
7.2
8.1
%
31.2
32.6
1.53
387
3355
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
105
740
1.48
3.26
4.8
9.9
mmol/l
23.8
23.6
0.32
100
714
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
116
834
1.45
3.26
10.8
9.7
mmol/l
1.5
1.0
1.08
97
602
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
251
2049
1.32
3.26
3.7
4.1
u/l
34.6
32.8
0.20
242
1967
(3037756) Immunofixation for Serum or Plasma
12
38
3.18
3.21
1.6
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
24
110
2.21
3.19
3.4
4.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
397
3456
1.29
3.17
6.9
7.9
%
53.9
52.8
1.00
383
3307
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
29
144
2.05
3.17
1.7
1.5
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
55
336
1.68
3.16
2.7
7.1
g/l
3.5
3.0
1.68
55
324
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
64
407
1.62
3.15
3.0
2.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
196
1552
1.34
3.12
2.8
2.9
u/l
53.1
55.6
0.31
185
1465
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
81
548
1.53
3.07
3.4
2.4
u/l
11471.2
3817.8
0.79
33
228
(3009343) pH of Capillary blood
116
844
1.43
3.06
10.9
9.7
ph
7.4
7.4
—
8
37
(3042111) Morphology [Interpretation] in Bone marrow Narrative
16
62
2.61
3.04
1.7
2.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
65
419
1.60
3.04
3.0
3.5
pmol/l
4.8
4.8
0.09
57
371
(3011412) CD3 cells [#/volume] in Blood
29
147
2.00
3.01
2.8
3.7
e9/l
1.1
1.5
2.20
20
95
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
26
128
2.06
2.92
1.5
1.2
u/ml
3.2
4.5
0.24
13
46
(3021960) Folate [Moles/volume] in Serum or Plasma
120
890
1.41
2.85
1.6
1.4
nmol/l
18.4
20.3
0.97
108
781
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
43
253
1.73
2.85
1.7
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
189
1512
1.32
2.78
3.7
3.9
mmol/l
8.1
8.3
0.18
174
1358
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
200
1615
1.31
2.75
1.9
1.7
pmol/l
100.3
97.3
0.30
94
878
(3018095) Leukocytes [#/volume] in Urine
260
2176
1.29
2.73
4.2
4.2
e6/l
60.8
77.2
0.23
198
1440
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
112
1476
0.72
2.73
2.2
2.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
19
85
2.26
2.70
2.7
5.8
—
—
—
0
0
(3036489) Thrombin time
56
360
1.59
2.67
2.6
6.1
s
21.9
22.7
0.57
51
334
(3044889) 12 lead EKG panel
382
3360
1.26
2.63
3.3
2.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
48
298
1.65
2.63
1.7
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
29
155
1.90
2.62
2.2
2.3
g/l
1.6
1.3
0.56
23
130
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
131
1002
1.36
2.59
3.2
3.2
e6/l
0.8
0.7
0.28
77
542
(3038177) Helicobacter pylori Ab [Presence] in Serum
22
108
2.06
2.52
1.2
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
640
6011
1.32
2.47
18.9
14.7
%
13.6
13.3
5.70
632
5930
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
25
130
1.95
2.46
6.7
16.2
u/ml
0.3
0.3
0.28
12
76
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
307
2649
1.25
2.45
3.8
4.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
12
45
2.68
2.44
3.7
2.8
u/ml
744.5
1072.9
0.58
12
45
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
13
51
2.57
2.44
2.2
2.6
mg/l
21.0
22.3
—
8
43
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
13
51
2.57
2.44
2.2
2.5
—
1.2
—
0
5
(3034860) Kappa light chains.free [Mass/volume] in Serum
13
51
2.57
2.44
2.2
2.6
mg/l
31.3
28.6
—
8
44
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
22
110
2.02
2.41
1.8
2.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
98
725
1.40
2.38
9.7
9.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
127
981
1.35
2.36
3.3
3.3
e6/l
4.4
2.5
0.81
73
522
(21494814) CD8 cells/100 lymphocytes in Specimen
8
22
3.65
2.36
2.9
2.5
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
7
17
4.13
2.35
1.1
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
175
1416
1.30
2.35
2.5
2.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
147
1164
1.32
2.31
2.8
3.2
umol/l
3748.0
3689.9
0.01
131
1065
(3051651) Icteric interference index of Serum or Plasma
15
65
2.33
2.31
2.3
3.9
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
24
126
1.93
2.31
1.5
1.2
u/ml
3.9
5.6
0.38
14
53
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
24
126
1.93
2.31
3.7
4.0
%
54.5
54.9
0.05
24
126
(21494755) Public health laboratory ask at order entry panel
64
904
0.68
2.31
1.2
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
27
148
1.85
2.29
1.5
1.6
g/l
0.7
0.7
0.11
20
123
(3024928) Oxygen saturation in Venous blood
24
128
1.90
2.22
5.5
18.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
8
24
3.35
2.17
1.3
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
23
122
1.91
2.16
3.3
3.6
e9/l
3.4
3.9
0.76
23
122
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
43
2.57
2.09
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
43
2.57
2.09
1.0
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
27
153
1.79
2.08
1.9
2.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
23
124
1.88
2.07
1.2
1.1
—
—
—
0
0
(4268621)
18
89
2.04
2.05
3.5
2.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
185
2190
0.79
2.02
2.8
2.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
30
178
1.71
1.99
1.5
1.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
41
265
1.57
1.97
1.6
1.5
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
24
134
1.81
1.95
2.6
3.7
e9/l
0.5
0.2
0.50
18
100
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
89
671
1.36
1.95
2.5
2.4
mmol/l
2.4
2.4
1.61
82
575
(3017143) Hepatitis C virus Ab [Presence] in Serum
133
1064
1.30
1.94
1.7
1.6
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
6
16
3.76
1.93
1.8
1.3
u/l
14.7
16.4
—
6
16
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
16
3.76
1.93
2.5
2.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
15
71
2.13
1.92
1.6
1.7
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
96
738
1.34
1.86
11.1
9.3
mmol/l
24.5
24.1
0.98
96
732
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
9
34
2.66
1.86
1.6
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
46
2.40
1.84
1.0
1.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
24
137
1.77
1.83
2.5
3.7
e6/l
385.2
565.3
1.86
18
101
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
6
17
3.54
1.83
3.2
2.9
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
17
3.54
1.83
2.2
2.1
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
10
40
2.51
1.83
1.4
1.1
%
90.2
90.0
—
5
21
(40761536) Microorganisms panel - Urine sediment
68
500
1.39
1.75
3.5
3.3
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
10
41
2.45
1.75
1.2
1.1
%
100.2
91.2
—
5
22
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
15
74
2.04
1.74
1.7
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
35
225
1.58
1.74
1.8
1.7
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
12
54
2.23
1.73
1.3
1.4
nmol/l
1.8
1.4
0.64
12
47
(40758558) Short blood count panel - Blood
216
1855
1.22
1.72
6.5
8.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
22
366
0.59
1.69
1.1
1.1
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
8
31
2.59
1.65
1.3
1.1
—
88.4
—
0
7
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
8
31
2.59
1.65
1.5
1.6
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
8
31
2.59
1.65
1.3
1.1
—
69.9
—
0
7
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
25
2.81
1.64
2.4
2.6
umol/l
25.7
18.3
—
7
25
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
60
438
1.40
1.63
5.9
5.6
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
5
14
3.58
1.61
1.2
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
14
3.58
1.61
1.0
2.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
62
457
1.38
1.59
5.0
4.8
e9/l
74.9
68.7
0.57
38
296
(4306422)
20
114
1.77
1.56
1.3
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
170
1441
1.22
1.53
3.0
2.7
mg/l
2.8
2.7
0.20
149
1276
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
101
806
1.29
1.53
1.5
1.5
pmol/l
496.1
37466372.5
1.31
84
734
(3001019) Free T4 and TSH panel - Serum or Plasma
31
462
0.66
1.52
2.3
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
21
2.86
1.50
1.5
2.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
49
351
1.42
1.49
1.5
1.8
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
15
79
1.91
1.49
1.2
1.5
mmol/l
10.6
11.3
—
5
12
(3031040) Bacteria [#/volume] in Urine by Automated count
416
3829
1.18
1.48
4.2
3.8
e6/l
471.7
50.7
—
9
40
(3037467) Urinalysis macro (dipstick) panel - Urine
450
4169
1.18
1.48
4.5
3.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
41
285
1.46
1.46
1.7
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
14
73
1.93
1.43
1.1
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
9
39
2.32
1.43
1.0
1.1
miu/ml
1284.1
1465.3
—
9
39
(3027315) Oxygen [Partial pressure] in Blood
19
110
1.74
1.42
2.6
5.1
kpa
8.6
9.4
1.30
19
110
(3013290) Carbon dioxide [Partial pressure] in Blood
19
110
1.74
1.42
2.7
5.1
kpa
5.3
4.9
1.92
19
110
(3021901) Oxygen saturation in Capillary blood
18
103
1.76
1.40
3.3
7.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
576
6009
0.84
1.40
3.7
3.9
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
760
7433
1.49
1.40
21.7
16.6
e9/l
258.6
263.6
1.15
740
7212
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
17
96
1.78
1.38
2.5
1.6
umol/l
3.8
4.6
0.45
17
87
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
29
190
1.54
1.37
1.5
3.7
e6/l
481.3
337.5
0.13
21
141
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
29
190
1.54
1.37
1.4
3.7
e6/l
4.2
10.9
0.70
20
135
(3023419) Bacteria identified in Sputum by Culture
9
41
2.20
1.37
2.4
5.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
20
120
1.68
1.34
2.3
3.9
e6/l
298.3
382.4
0.48
12
78
(3026389) Candida sp identified in Specimen by Organism specific culture
14
75
1.88
1.34
1.4
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
169
1452
1.20
1.33
3.1
2.7
ng/l
31.3
37.8
0.16
95
687
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
42
300
1.42
1.32
1.8
1.7
—
—
—
0
0
(3024731) MCV [Entitic volume]
760
7439
1.47
1.32
21.6
16.5
fl
89.4
88.4
6.03
753
7369
(3024891) Influenza virus A+B Ag [Presence] in Specimen
45
326
1.40
1.31
1.2
1.2
—
—
—
0
0
(3035941) MCH [Entitic mass]
760
7440
1.46
1.31
21.6
16.5
pg
29.9
29.7
2.41
753
7369
(3026361) Erythrocytes [#/volume] in Blood
760
7441
1.46
1.29
21.7
16.6
e12/l
4.6
4.6
1.36
739
7206
(3040151) Glucose [Moles/volume] in Capillary blood
14
76
1.85
1.29
3.7
5.8
mmol/l
4.8
6.5
—
9
69
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
47
345
1.38
1.28
1.6
1.6
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
9
44
2.05
1.26
3.4
1.9
%
128.7
124.0
—
9
44
(3000963) Hemoglobin [Mass/volume] in Blood
760
7445
1.45
1.24
22.3
16.8
g/l
135.7
135.9
0.12
754
7373
(3010813) Leukocytes [#/volume] in Blood
760
7445
1.45
1.24
21.7
16.6
e9/l
6.8
6.8
0.01
738
7203
(3020876) Protein [Mass/time] in 24 hour Urine
6
25
2.40
1.24
2.8
2.4
—
2.0
—
0
5
(40760892) CBC W Ordered Manual Differential panel - Blood
171
1482
1.19
1.23
4.7
5.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
19
2.63
1.21
1.8
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
8
37
2.17
1.21
2.8
2.8
—
—
—
0
0
(3013512) EKG study
125
1053
1.22
1.21
3.3
2.9
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
22
140
1.58
1.20
1.7
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
26
2.31
1.18
1.2
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
198
0.55
1.18
1.5
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
186
1631
1.18
1.17
2.0
1.7
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
14
79
1.78
1.16
2.2
4.3
umol/l
24.1
26.1
0.36
14
79
(3005082) Progesterone [Moles/volume] in Serum or Plasma
12
65
1.85
1.13
1.3
1.4
nmol/l
48.0
36.2
0.72
12
52
(3022670) pH of Venous cord blood
7
31
2.26
1.10
1.0
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
17
104
1.64
1.09
4.0
3.8
mg/l
26.9
21.8
0.36
11
73
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
21
2.38
1.09
1.6
1.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
41
1.96
1.08
1.1
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
8
41
1.96
1.08
1.5
2.7
mmol/l
4.1
4.0
—
8
41
(3018133) Calcium [Moles/volume] in Urine
14
81
1.74
1.08
3.0
4.0
mmol/l
2.6
2.6
0.00
14
75
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
14
81
1.74
1.08
1.3
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
44
331
1.34
1.06
2.8
2.7
ml/min/173m2
70.6
77.3
0.32
20
130
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
13
75
1.74
1.02
2.0
2.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
78
639
1.24
1.00
2.8
3.3
%
27.1
22.0
1.41
21
228
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
12
68
1.77
1.00
1.3
1.2
%
98.2
78.9
0.84
12
68
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
12
68
1.77
1.00
1.2
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
134
0.52
0.99
1.4
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
169
1492
1.16
0.98
4.6
3.5
estimate
0.0
0.0
1.34
65
548
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
23
2.18
0.98
1.6
1.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
562
5378
1.14
0.97
3.8
3.4
mmol/l
4.7
4.7
0.28
531
5126
(3011648) Oxygen content in Venous blood
14
84
1.67
0.97
5.4
25.1
%
12.6
11.5
0.89
14
84
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
0
32
0.00
0.95
0.0
2.0
—
7.1
—
0
26
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
211
2321
0.87
0.94
1.8
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
564
5404
1.14
0.94
4.0
3.6
mmol/l
2.9
2.9
0.30
530
5110
(4211845)
6
27
2.23
0.93
2.2
1.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
89
747
1.21
0.92
3.7
5.3
umol/l
5.5
6.6
0.64
72
626
(3021788) Differential panel - Synovial fluid
10
55
1.82
0.91
2.3
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
31
413
0.74
0.89
1.7
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
79
1.65
0.87
1.4
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
455
4315
1.12
0.86
4.5
4.0
mm/h
9.8
8.4
1.77
432
4048
(3029396) Erythrocyte agglutination [Presence] in Blood
6
31
1.94
0.84
2.7
3.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
15
96
1.57
0.84
1.5
2.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
16
236
0.67
0.82
1.4
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
29
384
0.74
0.81
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
29
384
0.74
0.81
1.5
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
73
1.65
0.81
1.7
1.9
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
16
235
0.67
0.81
1.4
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
14
89
1.58
0.81
1.8
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
24
172
1.40
0.80
1.2
4.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
47
1.70
0.80
1.0
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
29
383
0.75
0.80
1.5
1.4
—
—
—
0
0
(3020891) Body temperature
21
147
1.44
0.80
9.8
7.8
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
29
382
0.75
0.79
1.5
1.4
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
4.6
—
26.0
—
0
9
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
48
1.67
0.78
2.0
2.5
pg
29.8
32.4
—
8
48
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
15
98
1.54
0.78
1.5
1.7
mmol/l
7.5
7.6
—
7
59
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
12
74
1.63
0.77
2.4
1.9
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
1.0
—
80.2
—
0
20
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
1.0
—
19.4
—
0
19
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
516
4947
1.12
0.76
12.3
8.4
ml/min/173m2
96.0
96.1
0.03
412
3840
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
9
53
1.70
0.75
1.0
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
53
1.70
0.75
1.6
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
50
609
0.81
0.75
1.9
2.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
24
2.08
0.74
1.2
1.4
nmol/l
167.4
169.0
—
5
24
(3027008) Opiates [Presence] in Urine
50
606
0.81
0.72
1.8
2.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
60
1.67
0.71
1.0
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
40
1.75
0.71
2.0
2.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
7
40
1.75
0.71
1.6
2.8
mmol/l
102.4
105.6
—
7
40
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
40
1.75
0.71
1.6
2.8
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
26
1.92
0.70
1.6
1.7
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
26
1.92
0.70
2.4
1.9
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
34
265
1.29
0.70
1.5
1.4
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
7
41
1.71
0.70
1.9
2.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
41
1.71
0.70
1.1
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
50
603
0.82
0.69
1.9
2.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
27
1.85
0.68
1.2
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
116
0.60
0.68
2.3
1.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
554
5348
1.11
0.67
3.7
3.3
mmol/l
1.4
1.4
2.55
521
5076
(4146454)
5
28
1.79
0.66
6.4
3.2
—
—
—
0
0
(4024509)
5
28
1.79
0.66
1.0
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
5
28
1.79
0.66
1.8
1.8
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
16
224
0.71
0.65
1.1
1.1
u/ml
6.6
0.6
—
5
99
(3016879) Cocaine [Presence] in Urine
47
566
0.82
0.65
1.9
2.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
50
598
0.82
0.65
1.8
2.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
44
1.59
0.65
1.1
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
22
163
1.36
0.64
1.4
1.1
iu/ml
92.8
133.5
—
5
54
(3045424) Erythrocytes [Presence] in Urine
14
95
1.48
0.63
1.4
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
13
87
1.50
0.63
3.4
3.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
24
181
1.33
0.63
1.3
1.3
ug/g
348.1
328.2
0.27
15
102
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
26
334
0.77
0.62
1.2
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
138
1518
0.89
0.62
1.7
1.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
103
911
1.15
0.62
1.4
1.4
titre
1256.5
480.7
0.83
17
161
(3049233) Organic acids panel - Urine
5
30
1.67
0.61
1.0
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
39
475
0.81
0.61
1.4
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
96
1.46
0.61
1.4
1.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
21
0.00
0.60
0.0
4.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
208
0.71
0.59
1.1
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
406
4220
0.92
0.59
3.3
3.5
u/l
48.8
36.3
2.62
390
4056
(3000330) Specific gravity of Urine by Test strip
26
201
1.30
0.58
3.0
2.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
312
2946
1.09
0.58
5.4
4.7
estimate
0.0
0.0
0.50
64
566
(3041672) Baker's yeast Ab [Presence] in Serum
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
8
53
1.51
0.58
5.9
5.2
ug/l
26.1
20.5
—
8
53
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
55
465
1.19
0.58
3.7
3.1
%
31.6
31.6
0.01
38
343
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
123
1.39
0.57
1.8
1.7
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
36
1.67
0.56
1.8
3.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
81
1.48
0.56
2.3
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
14
98
1.43
0.56
2.4
4.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
24
306
0.78
0.56
1.4
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
11
73
1.51
0.56
1.3
2.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
124
1.38
0.55
1.2
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
65
1.54
0.55
1.1
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
27
338
0.79
0.55
1.0
1.3
miu/ml
59.9
248.6
—
6
171
(3010726) Horse dander IgE Ab [Units/volume] in Serum
29
359
0.80
0.54
1.1
1.2
u/ml
4.1
3.6
—
10
124
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
82
1.47
0.54
1.1
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
25
315
0.78
0.54
1.4
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
331
3145
1.09
0.53
3.6
3.2
ug/l
84.7
77.8
0.35
311
2987
(3002256) Pathology report gross observation
72
629
1.16
0.53
1.2
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
30
368
0.81
0.52
1.0
1.2
u/ml
4.3
6.0
0.40
17
264
(3009261) Glucose [Presence] in Urine by Test strip
313
2969
1.08
0.52
4.0
3.3
estimate
0.0
0.0
0.50
64
542
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
20
152
1.32
0.51
1.2
1.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
23
291
0.78
0.51
1.5
1.2
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
6
40
1.50
0.51
1.3
1.7
—
1021375.0
—
0
6
(4027681)
9
64
1.41
0.51
1.2
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
64
1.41
0.51
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
68
770
0.87
0.49
1.9
1.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
21
162
1.30
0.49
1.2
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
27
216
1.26
0.49
1.8
2.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
42
494
0.84
0.49
1.3
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
201
2137
0.92
0.48
1.8
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
310
2948
1.08
0.48
4.0
3.3
estimate
0.0
0.0
0.00
59
540
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
63
551
1.15
0.47
3.4
2.5
u/l
28.7
119.6
0.53
52
465
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
48
1.46
0.46
2.0
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
233
2193
1.08
0.46
4.3
3.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
53
606
0.86
0.45
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
24
192
1.25
0.44
1.8
2.0
iu/l
2.4
6.1
—
8
73
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
12
86
1.40
0.44
2.7
2.2
ug/min
102.3
109.5
—
7
52
(1001926) Buprenorphine [Presence] in Urine by Screen method
42
487
0.85
0.43
2.1
2.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
14
104
1.35
0.42
14.3
4.5
mmol/l
4.0
3.8
0.75
14
93
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
32
1.56
0.42
1.0
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
58
1.38
0.41
2.0
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
30
357
0.83
0.41
1.0
1.2
u/ml
5.0
1.1
0.93
17
234
(4133840)
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3019225) pH of Specimen
41
351
1.17
0.41
2.9
3.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
216
2039
1.08
0.40
2.2
2.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
34
1.47
0.40
2.6
3.9
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
60
1.33
0.40
1.3
1.4
nmol/l
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
8
61
1.31
0.39
1.0
1.4
pmol/l
325.3
567.0
—
8
44
(42529406) Shigella sp [Presence] in Stool by Culture
18
225
0.79
0.39
1.2
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
19
0.00
0.39
0.0
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
36
1.39
0.38
3.0
3.8
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
67
1.34
0.38
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
9
67
1.34
0.38
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
67
1.34
0.38
1.1
1.1
—
—
—
0
0
(1002224) Polysomnography panel
24
289
0.82
0.38
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
9
68
1.32
0.37
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
9
68
1.32
0.37
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
9
68
1.32
0.37
1.1
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
114
0.70
0.37
1.4
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
42
364
1.16
0.37
1.3
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
37
427
0.86
0.37
1.3
1.2
—
23.6
—
0
17
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
69
1.30
0.37
1.2
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
13
168
0.77
0.36
1.5
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
10
72
1.39
0.36
1.1
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
18
143
1.26
0.36
1.4
1.9
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
22
180
1.23
0.35
1.1
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
156
0.76
0.35
2.5
2.1
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
16
126
1.27
0.34
1.2
1.2
u/ml
0.5
2.9
—
8
38
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
44
1.36
0.34
1.2
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
44
1.36
0.34
1.7
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
44
1.36
0.34
1.3
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
27
227
1.19
0.34
1.4
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
13
100
1.30
0.33
1.4
3.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
26
219
1.19
0.32
2.0
2.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
6
47
1.28
0.32
1.3
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
47
1.28
0.32
4.2
2.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
83
1.33
0.31
1.1
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
142
0.77
0.31
2.3
1.9
—
—
—
0
0
(4035726)
44
389
1.14
0.31
1.3
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
18
218
0.82
0.31
1.2
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
31
356
0.86
0.30
2.0
1.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
524
5125
1.06
0.30
3.4
3.1
mmol/l
1.3
1.2
0.87
491
4876
(40761535) Cells panel - Urine sediment
29
334
0.86
0.30
7.2
3.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
30
259
1.16
0.29
3.3
4.6
ug/l
2.3
23.6
0.64
20
198
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
76
1.32
0.27
1.1
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
17
204
0.83
0.27
3.1
2.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
12
150
0.79
0.27
1.2
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
172
1637
1.06
0.27
3.3
2.8
—
—
—
0
0
(44813793)
8
66
1.21
0.26
1.1
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
25
215
1.16
0.26
1.8
2.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
10
126
0.79
0.24
1.0
1.2
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
24
207
1.16
0.24
1.4
1.7
—
266.7
—
0
6
(44806118)
18
151
1.19
0.24
1.9
2.2
—
—
—
0
0
(44790048)
18
151
1.19
0.24
1.9
2.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
87
926
0.93
0.24
1.9
1.8
%
1.4
1.4
0.21
80
863
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
87
1.26
0.24
1.4
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
667
6586
1.06
0.23
18.3
13.5
%
39.5
40.1
1.17
551
5678
(3014133) Dog dander IgE Ab [Units/volume] in Serum
22
253
0.86
0.23
1.3
1.1
u/ml
4.9
7.1
0.22
11
138
(3029075) Extractable nuclear Ab panel - Serum
5
38
1.31
0.23
1.6
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
38
1.31
0.23
1.4
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
91
964
0.93
0.23
2.0
2.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
18
153
1.18
0.22
2.1
3.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
78
729
1.07
0.21
1.8
2.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
42
1.19
0.21
1.2
1.8
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
11
0.00
0.21
0.0
2.6
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(4038314)
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.2
—
16.1
—
0
12
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
103
0.77
0.21
1.6
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
19
163
1.17
0.21
1.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
122
1160
1.06
0.20
1.6
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
27
302
0.89
0.20
1.4
1.4
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
3.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
16
136
1.18
0.19
1.3
2.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
134
1280
1.05
0.19
1.9
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
38
415
0.91
0.19
2.2
2.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
77
723
1.07
0.19
1.8
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
19
217
0.87
0.19
1.2
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
52
1.15
0.19
1.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
27
300
0.89
0.19
1.4
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
53
1.13
0.18
1.3
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
36
393
0.91
0.18
1.2
1.2
u/ml
8.8
2.3
0.72
19
240
(3020874) Milk IgE Ab [Units/volume] in Serum
18
156
1.15
0.18
1.1
1.5
u/ml
5.7
3.4
0.22
13
103
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
98
931
1.06
0.18
1.4
1.2
u/ml
2.7
7.2
2.05
38
366
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
60
1.16
0.17
1.3
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
60
1.16
0.17
1.1
1.4
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
20
176
1.14
0.17
1.1
1.1
u/ml
4.9
4.0
0.11
11
72
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
68
0.73
0.17
1.2
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
28
307
0.91
0.16
1.6
1.5
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
8
73
1.09
0.15
24.9
37.9
ug/l
116.6
150.7
—
8
67
(3039443) Prostate specific Ag panel - Serum or Plasma
6
78
0.77
0.15
1.5
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
80
1.12
0.15
1.9
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
81
1.11
0.15
1.1
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
51
478
1.07
0.14
1.9
2.3
ug/l
0.5
0.6
0.80
35
253
(3019150) Specific gravity of Urine by Refractometry
134
1292
1.04
0.14
5.0
3.3
kg/l
1.0
1.0
0.39
16
209
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
13
112
1.16
0.14
1.5
1.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
627
6206
1.04
0.13
19.5
14.9
g/l
333.5
334.4
1.68
622
6171
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
99
0.80
0.13
1.6
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
108
0.83
0.13
1.6
1.7
—
—
—
0
0
(44790047)
17
151
1.13
0.13
1.9
2.2
—
—
—
0
0
(44790049)
17
151
1.13
0.13
1.9
2.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
15
132
1.14
0.12
1.2
4.6
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
16
142
1.13
0.12
1.3
1.3
pmol/l
57.5
59.4
0.06
16
137
(3020393) Adenovirus Ag [Presence] in Stool
10
85
1.18
0.12
1.8
2.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
13
114
1.14
0.11
1.4
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
18
162
1.11
0.11
1.6
2.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
209
2046
1.03
0.10
1.8
1.9
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
5
47
1.06
0.09
1.2
1.2
u/l
78.2
180.1
—
5
32
(3005570) Glucose [Moles/volume] in Urine
5
48
1.04
0.09
1.0
1.7
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
54
1.11
0.09
1.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
6
55
1.09
0.09
1.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
24
223
1.08
0.08
1.8
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
97
1.13
0.08
1.2
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
57
1.05
0.08
1.2
1.9
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
29
307
0.94
0.08
1.3
1.8
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
58
1.03
0.08
1.8
1.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
60
0.83
0.08
1.2
4.9
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
60
0.83
0.08
1.2
4.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
37
388
0.95
0.08
1.2
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
22
235
0.93
0.08
1.1
1.1
u/ml
5.1
6.7
0.27
11
129
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
28
263
1.06
0.08
1.9
2.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
68
1.03
0.07
1.1
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
69
667
1.03
0.07
1.4
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
112
1141
0.98
0.07
2.3
3.0
ug/g
151.0
100.1
0.31
90
924
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
91
0.88
0.06
1.3
2.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
35
365
0.95
0.06
1.5
2.0
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
9
102
0.88
0.06
1.0
2.1
—
1546.7
—
0
6
(3000492) Spirometry study
64
620
1.03
0.06
1.3
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
19
177
1.07
0.06
1.4
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
29
303
0.95
0.05
1.3
1.9
u/ml
304.2
197.5
0.55
13
153
(3011397) Hemoglobin [Presence] in Urine by Test strip
147
1445
1.02
0.05
4.4
3.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
91
1.10
0.04
1.0
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
28
290
0.96
0.03
2.4
2.6
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
27
259
1.04
0.03
1.9
2.0
u/ml
104.0
96.6
—
7
33
(3022145) Colonoscopy Study observation
53
540
0.98
0.03
1.4
1.4
—
—
—
0
0
(4010399)
33
339
0.97
0.03
1.4
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
122
1.06
0.02
1.1
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
17
162
1.05
0.02
1.1
1.1
—
—
—
0
0
(3006598) pH of Arterial cord blood
16
167
0.95
0.02
1.0
1.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
31
317
0.97
0.01
1.7
2.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
48
485
0.99
0.00
1.5
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
115
1.04
0.00
1.3
1.7
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
10
97
1.03
0.00
1.8
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
44
443
0.99
0.00
2.4
2.4
e9/l
3.8
4.1
0.33
35
390
(3014599) Egg white IgE Ab [Units/volume] in Serum
16
159
1.00
0.00
1.1
1.4
u/ml
4.5
4.7
0.02
11
102
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
99
986
1.00
0.00
1.4
1.2
iu/ml
12.3
26.9
3.31
31
291
(4034850)
16
164
0.97
0.00
4.2
9.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
131
0.99
0.00
2.2
2.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
16
161
0.99
0.00
2.7
1.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
38
380
1.00
0.00
1.8
1.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
29
290
1.00
0.00
2.8
6.8
g/l
0.3
0.3
0.35
19
195
(3013862) HLA-DP [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
51
0.98
0.00
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
92
0.98
0.00
1.4
1.8
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
2.3
—
9.8
—
0
6
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
7
75
0.93
0.00
1.0
1.0
g/l
171.3
162.4
—
7
75
(3024869) Neuronal Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
60
1.00
0.00
1.5
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
59
0.84
0.00
1.2
1.3
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
243.2
—
0
6
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
21.9
—
0
5
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
59
1.01
0.00
1.5
1.4
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
8
87
0.92
0.00
1.0
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
52
0.96
0.00
1.2
2.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
60
1.00
0.00
1.5
1.4
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
9
89
1.01
0.00
1.2
1.5
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(4015189)
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
7
0.00
0.00
0.0
2.0
—
1.1
—
0
7
(3019174) dRVVT (LA screen)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
3.0
—
9295.8
—
0
6
(40760512) CD34 cells/100 cells in Bone marrow
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
59
1.01
0.00
1.5
1.4
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
4.1
—
—
—
0
0
(4198724)
7
77
0.91
0.00
1.7
1.8
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
60
1.00
0.00
1.5
1.4
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
70
1.00
0.00
1.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
6
0.00
0.00
0.0
8.7
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
7
0.00
0.00
0.0
2.9
—
2.9
—
0
7
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
60
1.00
0.00
1.5
1.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: Q17_CHROMOSOMAL_ABNORMALITI_NOT_ELSEW_CLASSIFIED – Chromosomal abnormalities, not elsewhere classified

GWS hits: 1

This endpoint is excluded (different definition than used in FinnGen).